Literature DB >> 8534765

Hypereosinophilic syndrome in Hodgkin's disease with increased granulocyte-macrophage colony-stimulating factor.

M Endo1, K Usuki, K Kitazume, K Iwabe, Y Okuyama, A Urabe.   

Abstract

We report a patient with eosinophilia accompanied by Hodgkin's disease who showed remarkable increase in granulocyte-macrophage colony-stimulating factor (GM-CSF) in plasma but no increase in interleukin-5 (IL-5). The plasma GM-CSF level normalized as eosinophilia and lymphadenopathy disappeared after chemotherapy. Immunohistochemical study with immunoperoxidase staining technique showed a positive stain in lymph node cells by monoclonal anti-GM-CSF antibody. Eosinophilia is often accompanied by Hodgkin's disease, and several cases have been reported to show high levels of plasma IL-5. To our knowledge, this is the first report to show a high level of plasma GM-CSF in Hodgkin's disease with eosinophilia.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8534765     DOI: 10.1007/bf01697986

Source DB:  PubMed          Journal:  Ann Hematol        ISSN: 0939-5555            Impact factor:   3.673


  8 in total

Review 1.  Interleukin-5, eosinophils, and disease.

Authors:  C J Sanderson
Journal:  Blood       Date:  1992-06-15       Impact factor: 22.113

2.  T cells from eosinophilic patients produce interleukin-5 with interleukin-2 stimulation.

Authors:  H Enokihara; S Furusawa; H Nakakubo; H Kajitani; S Nagashima; K Saito; H Shishido; Y Hitoshi; K Takatsu; T Noma
Journal:  Blood       Date:  1989-05-15       Impact factor: 22.113

3.  Detection of interleukin-5 messenger RNA in Reed-Sternberg cells of Hodgkin's disease with eosinophilia.

Authors:  M Samoszuk; L Nansen
Journal:  Blood       Date:  1990-01-01       Impact factor: 22.113

4.  GM-CSF and eosinophil chemotactic factors in an acute lymphoblastic leukemia patient with eosinophilia.

Authors:  R Kita; H Enokihara; S Nagashima; S Tsunogake; H Yamato; K Saito; S Furusawa; H Shishido; Y Fukushima; T Fukuda
Journal:  Acta Haematol       Date:  1993       Impact factor: 2.195

5.  Role of granulocyte-macrophage colony-stimulating factor, interleukin-3 and interleukin-5 in the eosinophilia associated with T cell lymphoma.

Authors:  J P Fermand; M T Mitjavila; J P Le Couedic; A Tsapis; R Berger; R Modigliani; M Seligmann; J C Brouet; W Vainchenker
Journal:  Br J Haematol       Date:  1993-03       Impact factor: 6.998

6.  Production of granulocyte-macrophage colony-stimulating factor in two patients with lung cancer, leukocytosis, and eosinophilia.

Authors:  C L Sawyers; D W Golde; S Quan; S D Nimer
Journal:  Cancer       Date:  1992-03-15       Impact factor: 6.860

7.  Blood eosinophilia in Hodgkin's disease. A follow-up of 25 cases in Venezuela.

Authors:  J J Desenne; G Acquatella; R Stern; A Muller; M Sánchez; R Somoza
Journal:  Cancer       Date:  1992-03-01       Impact factor: 6.860

8.  Adult T cell leukemia associated with eosinophilia: analysis of eosinophil-stimulating factors produced by leukemic cells.

Authors:  A Yano; M Yasukawa; K Yanagisawa; H Hasegawa; T Hato; Y Minamoto; H Kohno; T Kondo; S Fujita; Y Kobayashi
Journal:  Acta Haematol       Date:  1992       Impact factor: 2.195

  8 in total
  3 in total

1.  A young man with persistent eosinophilia.

Authors:  E Messa; D Cilloni; G Saglio
Journal:  Intern Emerg Med       Date:  2007-06       Impact factor: 3.397

2.  Mitral valve destruction by Hodgkin's lymphoma-associated Loefler endocarditis.

Authors:  Sergey Yalonetsky; David Mishaly; Ayelet Ben-Barak; Avraham Lorber
Journal:  Pediatr Cardiol       Date:  2007-11-15       Impact factor: 1.655

3.  Chronic Eosinophilic Leukemia-Not Otherwise Specified (NOS) in the Background of a Large Cell Lymphoma.

Authors:  Wilson I Gonsalves; Rong He; Animesh Pardanani; Vinay Gupta; Jacob P Smeltzer; Curtis A Hanson; Thomas E Witzig
Journal:  Case Rep Hematol       Date:  2013-10-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.